NeuroSeriesLive

CME Speakers

 

  • Edward J. Fox, MD, PhD

    Edward J. Fox, MD, PhD

    Edward J. Fox, MD, PhD

    Clinical Associate Professor of Neurology

    Edward Fox, MD, PhD, FAAN, is the director of the Multiple Sclerosis Clinic of Central Texas, and is the founding partner of Central Texas Neurology Consultants in Round Rock. Since starting a private neurology practice in 1992, he has been involved in numerous MS research protocols and has spoken internationally on topics related to neuroimmunology. His clinic has been designated a Center for Comprehensive MS Care by the National Multiple Sclerosis Society. Dr Fox is a longstanding member of the Consortium of Multiple Sclerosis Centers, is the president-elect of the Texas Neurological Society, and is also a clinical associate professor of neurology at the University of Texas Dell Medical School at Austin. He received his medical degree from Baylor College of Medicine in Houston.
  • Lori Mayer, DNP, MSCN

    Lori Mayer, DNP, MSCN

    Lori Mayer, DNP, MSCN

    Director, Medical Research

    Lori Mayer, DNP, MSN, RN, MSCN, is the director of medical research for the Multiple Sclerosis Clinic of Central Texas/Central Texas Neurology Consultants in Round Rock. She earned her doctorate in nursing practice at Rocky Mountain University in Provo, Utah and is a certified multiple sclerosis nurse. Dr Mayer has been involved in the clinical care of patients with MS and managing investigational clinical research since 2000. She has moderated numerous CME programs, and has presented at the International Organization of Multiple Sclerosis Nurses’ (IOMSN’s) MS CME and regional programs. She has published several articles and abstracts in peer-reviewed journals, is currently the chair of the IOMSN’s research committee, and is a board member of the Consortium of Multiple Sclerosis Centers.
  • Jerry S. Wolinsky, MD

    Jerry S. Wolinsky, MD

    Jerry S. Wolinsky, MD

    Emeritus Professor in Neurology

    Jerry S. Wolinsky, MD, is Professor Emeritus in the Department of Neurology at the McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth). He held the Bartels Family and Opal C. Rankin Professorships of Neurology at UTHealth, where he served as director of the Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center, and as a member of the graduate faculty of the Graduate School of Biomedical Sciences. Dr Wolinsky focuses on the design, implementation, conduct and analysis of clinical trials of multiple sclerosis, and basic and applied research in quantitative MRI analysis and MR spectroscopic imaging. He received his medical degree from the University of Illinois College of Medicine in Chicago.
  • Richard J. Barohn, MD

    Richard J. Barohn, MD

    Richard J. Barohn, MD

    Gertrude and Dewey Ziegler Professor of Neurology

    Richard J. Barohn, MD, is the vice chancellor for research, a University Distinguished Professor, and the Gertrude and Dewy Ziegler Professor, Department of Neurology, at the University of Kansas Medical Center (KU Medical Center) in Kansas City. His research focuses on myopathies (such as polymyositis and muscular dystrophy), motor neuron diseases (such as amyotrophic lateral sclerosis), peripheral neuropathies and myasthenia gravis. Dr Barohn is the principal investigator on the National Institutes of Health Clinical and Translational Science Award and the NeuroNEXT grant at KU Medical Center, and is Director of Frontiers: The University of Kansas Clinical and Translational Research Institute. He earned his medical degree from the University of Missouri-Kansas City School of Medicine.
  • Roy L. Freeman, MD

    Roy L. Freeman, MD

    Roy L. Freeman, MD

    Professor of Neurology

    Roy Freeman, MD, MB, ChB, is a professor of neurology at Harvard Medical School and director of the Center for Autonomic and Peripheral Nerve Disorders in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr Freeman’s research encompasses the neurological complications of diabetes, neuropathic pain, the autonomic complications of Parkinson’s disease and multiple system atrophy, biomarkers in neurodegenerative diseases, and the diagnosis and treatment of autonomic and peripheral nervous system disorders. He is the principal investigator on National Institutes of Health-funded studies on the neurological complications of diabetes and biomarker development in alpha-synucleinopathies, and on several neuropathic pain clinical trials.
  • Jonathan Katz, MD

    Jonathan Katz, MD

    Jonathan Katz, MD

    Adjunct Professor of Neurology

    Jonathan S. Katz, MD, is the director of the Forbes Norris MDA/ALS Research & Treatment Center at California Pacific Medical Center in San Francisco, as well as s an adjunct professor of neurology at the University of Kansas School of Medicine in Kansas City. His professional interests include amyotrophic lateral sclerosis, electromyography, motor neuron diseases, myasthenia gravis, neuromuscular disease, neuropathy testing, pain management, peripheral neuropathy, poliomyelitis - late effect, radiculopathies, and spinal muscular atrophy. Dr Katz has published extensively in the inflammatory neuropathies, use of IVIg, and in the area of amyotrophic lateral sclerosis. He earned his medical degree from Tulane University School of Medicine in New Orleans, Louisiana.
  • Amy Perrin Ross, APN, MSN, CNRN, MSCN

    Amy Perrin Ross, APN, MSN, CNRN, MSCN

    Amy Perrin Ross, APN, MSN, CNRN, MSCN

    Advanced Practice Nurse, Neuroscience Program Coordinator

    Amy Perrin Ross, APN, MSN, CNRN, MSCN, is currently the president of the International Organization of Multiple Sclerosis Nurses, and is the Neuroscience Program Coordinator at Loyola University Medical Center in Maywood, Illinois. She is involved in various organizations, including the Consortium of Multiple Sclerosis Centers, the National Multiple Sclerosis Society, and the Multiple Sclerosis Association of America. Ms Perrin Ross has been active in neuroscience clinical research for over 20 years. She speaks at numerous meetings and conferences, and has written several articles and book chapters on MS and dementia. She earned her BSN degree from Loyola University School of Nursing in Chicago, Illinois, and her MSN degree from Loyola University’s Graduate School of Nursing.
  • James D. Bowen, MD

    James D. Bowen, MD

    James D. Bowen, MD

    Clinical Associate Professor of Neurology

    James D. Bowen, MD, is medical director for the multiple sclerosis center at the Swedish Neuroscience Institute in Seattle, Washington, and is a clinical associate professor in the Department of Neurology at the University of Washington. Dr Bowen earned his medical degree at The Johns Hopkins University in Baltimore, Maryland, and completed a two-year residency in internal medicine and neurology at the University of Washington in Seattle. He is chair of the Professional Advisory Committee of the Greater Northwest Chapter of the National MS Society. Dr Bowen is a recipient of the Physician Leadership Award from the Swedish Medical Center, and has published more than 120 peer-reviewed journal articles, numerous book chapters and abstracts with a focus on multiple sclerosis.
  • Patricia K. Coyle, MD, FAAN, FANA

    Patricia K. Coyle, MD, FAAN, FANA

    Patricia K. Coyle, MD, FAAN, FANA

    Professor & Vice Chair (Clinical Affairs) Department of Neurology

    Patricia K. Coyle, MD, FAAN, FANA, is professor and vice chair (clinical affairs) of neurology, and director of the Multiple Sclerosis Comprehensive Care Center at Stony Brook University Medical Center in Stony Brook, New York. Dr Coyle is currently involved in various therapeutic trials testing new immunotherapies for multiple sclerosis (MS), as well as studies addressing neurologic aspects of Lyme disease. Her areas of expertise include Lyme disease and neurologic infections, cerebrospinal fluid, therapeutics and neuroimmunology, and she has authored several articles on the clinical/basic research aspects of MS and neurologic infections. She earned her MD from the Johns Hopkins University School of Medicine in Baltimore, Maryland, where she also completed her residency and fellowship.
  • Marie Namey, APRN, MSCN

    Marie Namey, APRN, MSCN

    Marie Namey, APRN, MSCN

    Clinical Nurse Specialist, Mellen Center for MS Treatment & Research

    Marie A. Namey, APRN, MSCN, is a clinical nurse specialist at the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic Foundation in Ohio. She earned her MSN degree from the Frances Payne Bolton School of Nursing at Case Western Reserve University in Cleveland, and her BSN degree from Villa Maria College in Erie, Pennsylvania. Ms Namey is a member of the local Multiple Sclerosis Society Chapter’s Professional Advisory Committee, a member of the Healthcare Advisory Council for the Multiple Sclerosis Association of America, and is a founding member and past president of the International Organization of Multiple Sclerosis Nurses. She has published several articles, and speaks for patient and professional groups on aspects of multiple sclerosis care.
  • Kenneth C. Gorson, MD

    Kenneth C. Gorson, MD

    Kenneth C. Gorson, MD

    Professor of Neurology, Department of Neurology

    Kenneth C. Gorson, MD, is a professor in the Department of Neurology at St. Elizabeth’s Medical Center, Tufts University School of Medicine in Boston, Massachusetts. He has published more than 90 original peer-reviewed research articles, book chapters, and reviews pertaining to Guillain-Barre´ syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), paraprotein associated neuropathies, vasculitic neuropathy, and various other inflammatory and immune-mediated disorders of the peripheral nervous system. Dr Gorson’s clinical and research expertise extends to patients with neuropathies associated with diabetes, connective tissue disorders, and cancer, inherited peripheral neuropathies, and disorders of muscle, myasthenia gravis, and amyotrophic lateral sclerosis.
  • Stephen P. Salloway, MD, MS

    Stephen P. Salloway, MD, MS

    Stephen P. Salloway, MD, MS

    Professor of Neurology and Psychiatry

    Stephen Salloway, MD, MS, is chief of neurology and director of the Memory and Aging Program at Butler Hospital, and professor of neurology and psychiatry at the Alpert Medical School of Brown University in Providence, Rhode Island. Under his direction, the Butler Hospital Memory and Aging Program has conducted more than 75 clinical trials developing new diagnostic tests and treatments for memory loss, and his program is currently conducting 5 prevention trials for individuals at high risk for Alzheimer’s disease (AD). Dr Salloway has published over 300 scientific articles and abstracts, edited 3 books, and lectures widely about early diagnosis and treatment of AD. He received his MD from Stanford Medical School, and completed residencies in neurology and psychiatry at Yale University.